Citations

Mayo Clinic

Showing 10 of 108572 citations.

Next-generation Multi-target Stool DNA Panel Accurately Detects Colorectal Cancer and Advanced Precancerous Lesions
Gagrat, Zubin D. , Krockenberger, Martin , Bhattacharya, Abhik , Gagrat, Bridget Z. , Leduc, Christine M. , Matter, Michael B. , Fourrier, Keith D. , Mahoney, Douglas W. , Edwards, David K. , Lidgard, Graham P. , Johnson, Scott C., Domanico, Michael J. , Edwards V, David K , Limburg, Paul J , Johnson, Scott C , Domanico, Michael J , Kisiel, John B , Mahoney, Douglas W , Limburg, Paul J. , Kisiel, John B.

Cancer Prevention Research | January 15, 2024 | Volume: 17 | Issue: 3 | Pages: 119-126

10.1158/1940-6207.capr-23-0285 | PMID 38224564 Get It

Abstract The multi-target stool DNA (mt-sDNA) test screens for colorectal cancer by analyzing DNA methylation/mutation and hemoglobin markers to algorithmically derive a qualitative result. A new panel of highly discriminant candidate methylated DNA markers (MDM) was recently developed. Performance of the novel MDM panel, with hemoglobin, was evaluated in a simulated screening population using archived stool samples weighted to early-stage colorectal cancer and prospectively collected advanced precancerous lesions (APL). Marker selection study (MSS) and separate preliminary independent verification studies (VS) were conducted utilizing samples from multi-center, case–control studies. Sample processing included targeted MDM capture, bisulfite conversion, and MDM quantitation. Fecal hemoglobin was quantified using ELISA. Samples were stratified into 75%/25% training-testing sets; model outcomes were cross-validated 1,000 times. All laboratory operators were blinded. The MSS included 232 cases (120 colorectal cancer/112 APLs) and 490 controls. The VS featured 210 cases (112 colorectal cancer/98 APLs) and 567 controls; APLs were 86.7% adenomas and 13.3% sessile serrated lesions (SSL). Average age was 65.5 (cases) and 63.2 (controls) years. Mean sensitivity in the VS from cross-validation was 95.2% for colorectal cancer and 57.2% for APLs, with specificities of 89.8% (no CRC/APLs) and 92.4% (no neoplasia). Subgroup analyses showed colorectal cancer sensitivities of 93.4% (stage I) and 94.2% (stage II). APL sensitivity was 82.9% for high-grade dysplasia, 73.4% for villous lesions, 49.8% for tubular lesions, and 30.2% for SSLs. These data support high sensitivity and specificity for a next-generation mt-sDNA test panel. Further evaluation of assay performance will be characterized in a prospective, multi-center clinical validation study (NCT04144738). Prevention Relevance: This study highlights performance of the next-generation mt-sDNA test, which exhibits high sensitivity and specificity for detecting colorectal cancer and APLs. This noninvasive option has potential to increase screening participation and clinical outcomes. A multi-center, clinical validation trial is underway. See related commentary by Bresalier, p. 93
Reflections on physiology and modelling
Joyner, Michael J. , Joyner, Michael J

Experimental Physiology | January 15, 2024 | Volume: 110 | Issue: 5 | Pages: 634-636

10.1113/ep091711 | PMID 38224249 Get It

Comprehensive measurement of muscle maximal oxygen uptake determinants: insights and application
Webb, Kevin L. , Zaremba, Solomiia , Pruter, Wyatt W. , Miller, Alex J. , Sears, Kylie N., Webb, Kevin L , Zaremba, Solomiia

The Journal of Physiology | January 15, 2024 | Volume: 602 | Issue: 3 | Pages: 423-425

10.1113/jp286095 | PMID 38224247 Get It

Application of Advanced Imaging to Prostate Cancer Diagnosis and Management: A Narrative Review of Current Practice and Unanswered Questions
McKone, Elizabeth L. , Sutton, Elsa A., Johnson, Geoffrey B. , Phillips, Ryan , Phillips, Ryan M., Johnson, Geoffrey B

Journal of Clinical Medicine | January 15, 2024 | Volume: 13 | Issue: 2 | Pages: 446

10.3390/jcm13020446 | PMID 38256579 Get It

Major advances in prostate cancer diagnosis, staging, and management have occurred over the past decade, largely due to our improved understanding of the technical aspects and clinical applications of advanced imaging, specifically magnetic resonance imaging (MRI) and prostate-cancer-specific positron emission tomography (PET). Herein, we review the established utility of these important and exciting technologies, as well as areas of controversy and uncertainty that remain important areas for future study. There is strong evidence supporting the utility of MRI in guiding initial biopsy and assessing local disease. There is debate, however, regarding how to best use the imaging modality in risk stratification, treatment planning, and assessment of biochemical failure. Prostate-cancer-specific PET is a relatively new technology that provides great value to the evaluation of newly diagnosed, treated, and recurrent prostate cancer. However, its ideal use in treatment decision making, staging, recurrence detection, and surveillance necessitates further research. Continued study of both imaging modalities will allow for an improved understanding of their best utilization in improving cancer care.
Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck Tumors
Foote, Robert L. , Harmsen, W. Scott, Amundson, A., Gamez, Mauricio E. , Garces, Yolanda I. , Lester, Scott C. , McGee, L.A. , Moore, Eric J. , Wittich, Michelle A. Neben, Patel, Samir H. , Rwigema, Jean‐Claude M. , Abel, Kathryn M. Van , Yin, Linda X. , Muller, Olivia M. , Shiraishi, Satomi , Amundson, Adam C., Carr, Alan B. , Lester, Scott , McGee, Lisa A, Neben Wittich, Michelle A, Yin, Linda X , Van Abel, Kathryn M , Foote, Robert , Shiraishi, Satomi , Daniel, J. , Routman, David M.

Cancers | January 15, 2024 | Volume: 16 | Issue: 2 | Pages: 349

10.3390/cancers16020349 | PMID 38254837 Get It

Background: Approximately 75% of all head and neck cancer patients are treated with radiotherapy (RT). RT to the oral cavity results in acute and late adverse events which can be severe and detrimental to a patient’s quality of life and function. The purpose of this study was to explore associations between RT dose to a defined oral cavity organ-at-risk (OAR) avoidance structure, provider- and patient-reported outcomes (PROs), opioid use, and hospitalization. Methods: This was a retrospective analysis of prospectively obtained outcomes using multivariable modeling. The study included 196 patients treated with RT involving the oral cavity for a head and neck tumor. A defined oral cavity OAR avoidance structure was used in all patients for RT treatment planning. Validated PROs were collected prospectively. Opioid use and hospitalization were abstracted electronically from medical records. Results: Multivariable modeling revealed the mean dose to the oral cavity OAR was significantly associated with opioid use (p = 0.0082) and hospitalization (p = 0.0356) during and within 30 days of completing RT. Conclusions: The findings of this study may be valuable in RT treatment planning for patients with tumors of the head and neck region to reduce the need for opioid use and hospitalization during treatment.
Chain of Thought Utilization in Large Language Models and Application in Nephrology
Miao, Jing , Krisanapan, Pajaree , Cheungpasitporn, Wisit , Krisanapan, Pajaree , Cheungpasitporn, Wisit , Miao, Jing , Thongprayoon, Charat , Suppadungsuk, Supawadee , Radhakrishnan, Yeshwanter

Medicina | January 15, 2024 | Volume: 60 | Issue: 1 | Pages: 148

10.3390/medicina60010148 | PMID 38256408 Get It

Chain-of-thought prompting enhances the abilities of large language models (LLMs) significantly. It not only makes these models more specific and context-aware but also impacts the wider field of artificial intelligence (AI). This approach broadens the usability of AI, increases its efficiency, and aligns it more closely with human thinking and decision-making processes. As we improve this method, it is set to become a key element in the future of AI, adding more purpose, precision, and ethical consideration to these technologies. In medicine, the chain-of-thought prompting is especially beneficial. Its capacity to handle complex information, its logical and sequential reasoning, and its suitability for ethically and context-sensitive situations make it an invaluable tool for healthcare professionals. Its role in enhancing medical care and research is expected to grow as we further develop and use this technique. Chain-of-thought prompting bridges the gap between AI’s traditionally obscure decision-making process and the clear, accountable standards required in healthcare. It does this by emulating a reasoning style familiar to medical professionals, fitting well into their existing practices and ethical codes. While solving AI transparency is a complex challenge, the chain-of-thought approach is a significant step toward making AI more comprehensible and trustworthy in medicine. This review focuses on understanding the workings of LLMs, particularly how chain-of-thought prompting can be adapted for nephrology’s unique requirements. It also aims to thoroughly examine the ethical aspects, clarity, and future possibilities, offering an in-depth view of the exciting convergence of these areas.
Guidance for assessment of the inflammation etiologic criterion for the GLIM diagnosis of malnutrition: A modified Delphi approach
Jensen, Gordon L. , Cederholm, Tommy , Ballesteros‐Pomar, María D. , Correia, María Isabel Toulson Davisson , Cuerda, Cristina , Evans, David C. , Fukushima, Ryoji , Ochoa, Juan B. , González, Marı́a Cristina , Gossum, A. Van , Hartono, Joseph, Manzanares, William , McMahon, M. Molly , Mendez, Yolanda , Muscaritoli, Maurizio , Nogales, Guillermo Contreras , Nyulasi, Ibolya , Phillips, Wendy , Pirlich, Matthias , Pisprasert, Veeradej , Winkler, Marion F. , Compher, Charlene , Barazzoni, Rocco , Blaauw, Renee , Gautier, Juan B Ochoa , Cuerda, Cristina , Evans, David C , Fukushima, Ryoji , Gautier, Juan Bernardo Ochoa , Gonzalez, M Cristina , Gramlich, Leah , Heymsfield, Steven B , Jager-Wittenaar, Harriët , Jayatissa, Renuka , Keller, Heather , Malone, Ainsley , Manzanares, William , Mendez, Yolanda , Mogensen, Kris M , Mori, Naoharu , Muscaritoli, Maurizio , Nogales, Guillermo Contreras , Pisprasert, Veeradej , Rothenberg, Elisabet , de van der Schueren, Marian , Shi, Han Ping , Steiber, Alison , Winkler, Marion F , Compher, Charlene , Gramlich, Leah , Heymsfield, Steven B. , Malone, Ainsley , Mogensen, Kris M.

Journal of Parenteral and Enteral Nutrition | January 15, 2024 | Volume: 48 | Issue: 2 | Pages: 145-154

10.1002/jpen.2590 | PMID 38221842 Get It

Abstract Background The Global Leadership Initiative on Malnutrition (GLIM) approach to malnutrition diagnosis is based on assessment of three phenotypic (weight loss, low body mass index, and reduced skeletal muscle mass) and two etiologic (reduced food intake/assimilation and disease burden/inflammation) criteria, with diagnosis confirmed by fulfillment of any combination of at least one phenotypic and at least one etiologic criterion. The original GLIM description provided limited guidance regarding assessment of inflammation, and this has been a factor impeding further implementation of the GLIM criteria. We now seek to provide practical guidance for assessment of inflammation. Methods A GLIM‐constituted working group with 36 participants developed consensus‐based guidance through a modified Delphi review. A multiround review and revision process served to develop seven guidance statements. Results The final round of review was highly favorable, with 99% overall “agree” or “strongly agree” responses. The presence of acute or chronic disease, infection, or injury that is usually associated with inflammatory activity may be used to fulfill the GLIM disease burden/inflammation criterion, without the need for laboratory confirmation. However, we recommend that recognition of underlying medical conditions commonly associated with inflammation be supported by C‐reactive protein (CRP) measurements when the contribution of inflammatory components is uncertain. Interpretation of CRP requires that consideration be given to the method, reference values, and units (milligrams per deciliter or milligram per liter) for the clinical laboratory that is being used. Conclusion Confirmation of inflammation should be guided by clinical judgment based on underlying diagnosis or condition, clinical signs, or CRP.
Response to “The importance of diversity in Obesity articles”
Jensen, Michael D. , Redman, Leanne M. , Jensen, Michael , Redman, Leanne

Obesity | January 15, 2024 | Volume: 32 | Issue: 3 | Pages: 444-444

10.1002/oby.23982 | PMID 38220247 Get It

Assessing cardiovascular disease risk in women with a history of hypertensive disorders of pregnancy: A guidance paper for studies using administrative data
Johnston, Amy , Smith, Graeme N. , Coutinho, Thais , Smith, Graeme N , Tanuseputro, Peter , Edwards, Jodi D.

Paediatric and Perinatal Epidemiology | January 15, 2024 | Volume: 38 | Issue: 3 | Pages: 254-267

10.1111/ppe.13043 | PMID 38220144 Get It

AbstractBackgroundHypertensive disorders of pregnancy (HDP) are a major cause of maternal morbidity and mortality, and their association with increased cardiovascular disease (CVD) risk represents a major public health concern. However, assessing CVD risk in women with a history of these conditions presents unique challenges, especially when studies are carried out using routinely collected data.ObjectivesTo summarise and describe key challenges related to the design and conduct of administrative studies assessing CVD risk in women with a history of HDP and provide concrete recommendations for addressing them in future research.MethodsThis is a methodological guidance paper.ResultsSeveral conceptual and methodological factors related to the data‐generating mechanism and study conceptualisation, design/data management and analysis, as well as the interpretation and reporting of study findings should be considered and addressed when designing and carrying out administrative studies on this topic. Researchers should develop an a priori conceptual framework within which the research question is articulated, important study variables are identified and their interrelationships are carefully considered.ConclusionsTo advance our understanding of CVD risk in women with a history of HDP, future studies should carefully consider and address the conceptual and methodological considerations outlined in this guidance paper. In highlighting these challenges, and providing specific recommendations for how to address them, our goal is to improve the quality of research carried out on this topic.
Increasing Exposure to Inflammatory Bowel Diseases Education in Gastroenterology Fellowship: The Pilot IBD 101 Experience
Hong, Simon , Lopatin, Sarah, Murphy, Megan E. , Kane, Sunanda V. , Malter, Lisa , Kane, S , Hudesman, David , Rubin, David T.

Inflammatory Bowel Diseases | January 13, 2024 | Volume: 31 | Issue: 3 | Pages: 746-750

10.1093/ibd/izad311 | PMID 38217539 Get It

Abstract Background Inflammatory bowel disease (IBD) management has become increasingly complex, and education varies across fellowship programs. IBD 101 was designed to introduce first-year gastroenterology (GI) fellows to IBD care and training. Methods In 2019, a cohort of fellows participated in a 1-day course with small group learning and group observed structured clinical examinations. Pre- and postcourse surveys were administered to evaluate the course. To assess the long-term impact, surveys were emailed in May 2022 to all third-year fellows from previously participating programs. The primary outcome was comfort managing IBD scenarios and information regarding each fellow’s exposure to IBD education. Results Fifty-five fellows from 32 programs participated. A total of 49 (89%) of 55 completed pre- and postcourse surveys. All fellows agreed that the course content was appropriate. In the postcourse survey, all fellows reported increased comfort managing IBD patients. Ninety-six percent of attendees stated that they would strongly recommend this course. Thirty-six fellows completed surveys in 2022, 21 (58%) attendees and 15 (42%) nonattendees. Attendees reported equivalent or higher levels of comfort compared with nonattendees. Higher global competence was noted among attendees (odds ratio, 5.21; 95% confidence interval, 0.91-29.9; P = .06) after adjusting for presence of a local IBD specialist, number of IBD patients seen monthly (≤5 vs >5), and rotation through an IBD service. Conclusions IBD 101, an introductory course for first-year GI trainees, was associated with increased comfort managing IBD with a durable benefit independent of individual access to IBD education. Continuation of this program will further enhance the IBD education of future GI fellows.